Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.27
LPNT's Cash to Debt is ranked higher than
68% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. LPNT: 0.27 )
LPNT' s 10-Year Cash to Debt Range
Min: 0.01   Max: 0.38
Current: 0.27

0.01
0.38
Equity to Asset 0.40
LPNT's Equity to Asset is ranked higher than
67% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. LPNT: 0.40 )
LPNT' s 10-Year Equity to Asset Range
Min: 0.21   Max: 0.57
Current: 0.4

0.21
0.57
F-Score: 6
Z-Score: 1.68
M-Score: -2.63
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 5.75
LPNT's Operating margin (%) is ranked higher than
65% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 9.71 vs. LPNT: 5.75 )
LPNT' s 10-Year Operating margin (%) Range
Min: -1.3   Max: 16.15
Current: 5.75

-1.3
16.15
Net-margin (%) 3.49
LPNT's Net-margin (%) is ranked higher than
69% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. LPNT: 3.49 )
LPNT' s 10-Year Net-margin (%) Range
Min: -4.37   Max: 8.6
Current: 3.49

-4.37
8.6
ROE (%) 5.80
LPNT's ROE (%) is ranked higher than
65% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 9.92 vs. LPNT: 5.80 )
LPNT' s 10-Year ROE (%) Range
Min: -18.37   Max: 17.37
Current: 5.8

-18.37
17.37
ROA (%) 2.29
LPNT's ROA (%) is ranked higher than
65% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. LPNT: 2.29 )
LPNT' s 10-Year ROA (%) Range
Min: -6.14   Max: 9.62
Current: 2.29

-6.14
9.62
ROC (Joel Greenblatt) (%) 7.89
LPNT's ROC (Joel Greenblatt) (%) is ranked higher than
62% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 17.97 vs. LPNT: 7.89 )
LPNT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2.21   Max: 28.79
Current: 7.89

-2.21
28.79
Revenue Growth (%) 13.60
LPNT's Revenue Growth (%) is ranked higher than
88% of the 182 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. LPNT: 13.60 )
LPNT' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 28.2
Current: 13.6

0
28.2
EBITDA Growth (%) -0.10
LPNT's EBITDA Growth (%) is ranked higher than
66% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. LPNT: -0.10 )
LPNT' s 10-Year EBITDA Growth (%) Range
Min: -0.1   Max: 68.4
Current: -0.1

-0.1
68.4
EPS Growth (%) -2.70
LPNT's EPS Growth (%) is ranked higher than
65% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 9.80 vs. LPNT: -2.70 )
LPNT' s 10-Year EPS Growth (%) Range
Min: -2.7   Max: 46.2
Current: -2.7

-2.7
46.2
» LPNT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

LPNT Guru Trades in Q1 2013

Ray Dalio 38,407 sh (New)
Larry Robbins 3,620,895 sh (+50.73%)
Jeremy Grantham 15,035 sh (+5.55%)
David Dreman 812,199 sh (-4.28%)
Paul Tudor Jones 10,900 sh (-35.5%)
Steven Cohen 133,557 sh (-49.07%)
HOTCHKIS & WILEY 847,300 sh (-54.69%)
Diamond Hill Capital 87,338 sh (-84.82%)
» More
Q2 2013

LPNT Guru Trades in Q2 2013

Paul Tudor Jones 14,500 sh (+33.03%)
HOTCHKIS & WILEY 955,000 sh (+12.71%)
Jeremy Grantham 15,772 sh (+4.9%)
Ray Dalio Sold Out
Larry Robbins 3,620,345 sh (-0.02%)
Diamond Hill Capital 83,383 sh (-4.53%)
David Dreman 683,154 sh (-15.89%)
Steven Cohen 7,809 sh (-94.15%)
» More
Q3 2013

LPNT Guru Trades in Q3 2013

Jim Simons 197,830 sh (New)
Ray Dalio 14,401 sh (New)
Steven Cohen 17,623 sh (+125.68%)
HOTCHKIS & WILEY 1,018,600 sh (+6.66%)
Larry Robbins 3,620,345 sh (unchged)
Diamond Hill Capital 83,343 sh (-0.05%)
Jeremy Grantham 14,200 sh (-9.97%)
Paul Tudor Jones 12,500 sh (-13.79%)
David Dreman 178,998 sh (-73.8%)
» More
Q4 2013

LPNT Guru Trades in Q4 2013

Joel Greenblatt 226,690 sh (New)
Larry Robbins 4,580,637 sh (+26.52%)
Ray Dalio 17,361 sh (+20.55%)
Paul Tudor Jones 14,281 sh (+14.25%)
David Dreman 202,411 sh (+13.08%)
Diamond Hill Capital 88,068 sh (+5.67%)
Steven Cohen Sold Out
Jim Simons Sold Out
HOTCHKIS & WILEY 1,015,100 sh (-0.34%)
Jeremy Grantham 13,446 sh (-5.31%)
» More
» Details

Insider Trades

Latest Guru Trades with LPNT

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 New Buy0.29%$47.22 - $52.54 $ 53.517%226690
Ray Dalio 2013-12-31 Add 20.55%$47.22 - $52.54 $ 53.517%17361
David Dreman 2013-09-30 Reduce -73.8%0.67%$44.52 - $51.57 $ 53.5112%178998
Ray Dalio 2013-09-30 New Buy0.01%$44.52 - $51.57 $ 53.5112%14401
David Dreman 2013-06-30 Reduce -15.89%0.16%$44.25 - $53.07 $ 53.5112%683154
Ray Dalio 2013-06-30 Sold Out 0.02%$44.25 - $53.07 $ 53.5112%0
Ray Dalio 2013-03-31 New Buy0.02%$37.75 - $48.5 $ 53.5122%38407
Joel Greenblatt 2012-03-31 Sold Out 0.12%$35.58 - $41.63 $ 53.5146%0
Joel Greenblatt 2011-12-31 New Buy0.12%$33.44 - $40.34 $ 53.5143%27684
Ray Dalio 2011-12-31 Sold Out 0.11%$33.44 - $40.34 $ 53.5143%0
Ray Dalio 2011-09-30 Add 107.95%0.06%$29.16 - $40.43 $ 53.5151%203274
George Soros 2011-09-30 Sold Out 0.0325%$29.16 - $40.43 $ 53.5150%0
George Soros 2011-06-30 Add 556.67%0.03%$37.88 - $43.27 $ 53.5133%59100
John Hussman 2011-03-31 Sold Out $34.84 - $39.9 $ 53.5144%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about LifePoint Hospitals Inc

The Skinny on Health Care Stocks - Second Quarter Trades
A number of stocks in the health care sector are up over 12 months, and according to GuruFocus research, the billionaires are trading. The GuruFocus Buffett-Munger Screener highlights these medical and health care companies, and others, with high predictability and EBITDA growth rates. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 19.90
LPNT's P/E(ttm) is ranked higher than
77% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 21.80 vs. LPNT: 19.90 )
LPNT' s 10-Year P/E(ttm) Range
Min: 9.56   Max: 32.67
Current: 19.9

9.56
32.67
P/B 1.10
LPNT's P/B is ranked higher than
92% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. LPNT: 1.10 )
LPNT' s 10-Year P/B Range
Min: 0.56   Max: 3.38
Current: 1.1

0.56
3.38
P/S 0.70
LPNT's P/S is ranked higher than
79% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. LPNT: 0.70 )
LPNT' s 10-Year P/S Range
Min: 0.36   Max: 1.88
Current: 0.7

0.36
1.88
PFCF 15.00
LPNT's PFCF is ranked higher than
75% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 15.52 vs. LPNT: 15.00 )
LPNT' s 10-Year PFCF Range
Min: 6.03   Max: 44.11
Current: 15

6.03
44.11
EV-to-EBIT 22.20
LPNT's EV-to-EBIT is ranked higher than
60% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 17.77 vs. LPNT: 22.20 )
LPNT' s 10-Year EV-to-EBIT Range
Min: 7.3   Max: 25.1
Current: 22.2

7.3
25.1
PEG 16.60
LPNT's PEG is ranked lower than
58% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 1.93 vs. LPNT: 16.60 )
LPNT' s 10-Year PEG Range
Min: 0.43   Max: 17.74
Current: 16.6

0.43
17.74
Shiller P/E 18.70
LPNT's Shiller P/E is ranked higher than
88% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 24.97 vs. LPNT: 18.70 )
LPNT' s 10-Year Shiller P/E Range
Min: 8.79   Max: 45.13
Current: 18.7

8.79
45.13

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.20
LPNT's Price/Tangible Book is ranked higher than
51% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. LPNT: 5.20 )
LPNT' s 10-Year Price/Tangible Book Range
Min: 3.73   Max: 21.7
Current: 5.2

3.73
21.7
Price/DCF (Projected) 0.70
LPNT's Price/DCF (Projected) is ranked higher than
91% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. LPNT: 0.70 )
LPNT' s 10-Year Price/DCF (Projected) Range
Min: 0.44   Max: 2.94
Current: 0.7

0.44
2.94
Price/Median PS Value 1.00
LPNT's Price/Median PS Value is ranked higher than
81% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. LPNT: 1.00 )
LPNT' s 10-Year Price/Median PS Value Range
Min: 0.66   Max: 4.05
Current: 1

0.66
4.05
Price/Graham Number 2.10
LPNT's Price/Graham Number is ranked higher than
64% of the 104 Companies
in the Global Medical Care industry.

( Industry Median: 2.38 vs. LPNT: 2.10 )
LPNT' s 10-Year Price/Graham Number Range
Min: 1.59   Max: 9.33
Current: 2.1

1.59
9.33
Earnings Yield (Greenblatt) 4.50
LPNT's Earnings Yield (Greenblatt) is ranked higher than
61% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 5.30 vs. LPNT: 4.50 )
LPNT' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4   Max: 13.6
Current: 4.5

4
13.6
Forward Rate of Return (Yacktman) 6.61
LPNT's Forward Rate of Return (Yacktman) is ranked higher than
71% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. LPNT: 6.61 )
LPNT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 7.3   Max: 27.2
Current: 6.61

7.3
27.2

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:LPO.Germany
LifePoint Hospitals, Inc., a Delaware corporation, acting through its subsidiaries, operates general acute care hospitals primarily in non-urban communities in the United States. At December 31, 2012, on a consolidated basis, the Company operated 56 hospital campuses in 19 states. The Company's hospitals typically provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services, pediatric services, and, in some of the Company's hospitals, specialized services such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. In many markets, it also provides outpatient services such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy. The services provided at any specific hospital depend on factors such as community need for the service, whether physicians necessary to operate the service line safely are members of the medical staff of that hospital, whether the service might be economically viable, and any contractual or certificate of need restrictions that might exist. Like most hospitals located in non-urban markets, LifePoint Hospitals, Inc do not engage in extensive medical research and medical education programs. However, two of the Company's hospitals have an affiliation with medical schools, including the clinical rotation of medical students, and one of its hospitals owns and operates a school of health professions with a nursing program and a radiologic technology program. The Company maintains quality assurance programs to support and monitor quality of care standards and to meet accreditation and regulatory requirements. The Company also monitors patient care evaluations and other quality of care assessment activities on a regular basis.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide